AAAAAA
Results:
1-15
|
Results: 15
Authors:
Reles, A
Wen, WH
Schmider, A
Gee, C
Runnebaum, IB
Kilian, U
Jones, LA
El-Naggar, A
Minguillon, C
Schonborn, I
Reich, O
Kreienberg, R
Lichtenegger, W
Press, MF
Citation: A. Reles et al., Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer, CLIN CANC R, 7(10), 2001, pp. 2984-2997
Authors:
Silverstein, MJ
Burak, WE
Clough, K
Edwards, MJ
Fine, RE
Gittleman, MA
Harms, SE
Harness, JK
Heywang-Koebrunner, SH
Holland, R
Krag, DN
Kuske, RR
Lagios, MD
Page, D
Press, MF
Recht, A
Robinson, D
Rubin, E
Schwartz, GF
Tabar, L
Vicini, F
Waisman, JR
Citation: Mj. Silverstein et al., Image-detected breast cancer: State of the art diagnosis and treatment, J AM COLL S, 193(3), 2001, pp. 297-302
Authors:
Lukas, J
Gao, DQ
Keshmeshian, M
Wen, WH
Tsao-Wei, D
Rosenberg, S
Press, MF
Citation: J. Lukas et al., Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer, CANCER RES, 61(7), 2001, pp. 3212-3219
Authors:
McKean-Cowdin, R
Kolonel, LN
Press, MF
Pike, MC
Henderson, BE
Citation: R. Mckean-cowdin et al., Germ-line HER-2 variant and breast cancer risk by stage of disease, CANCER RES, 61(23), 2001, pp. 8393-8394
Authors:
Schmider, A
Gee, C
Friedmann, W
Lukas, JJ
Press, MF
Lichtenegger, W
Reles, A
Citation: A. Schmider et al., p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma, GYNECOL ONC, 77(2), 2000, pp. 237-242
Authors:
Zheng, WX
Luo, F
Lu, JJ
Baltayan, A
Press, MF
Zhang, ZF
Pike, MC
Citation: Wx. Zheng et al., Reduction of BRCA1 expression in sporadic ovarian cancer, GYNECOL ONC, 76(3), 2000, pp. 294-300
Authors:
Park, JJ
Irvine, RA
Buchanan, G
Koh, SS
Park, JM
Tilley, WD
Stallcup, MR
Press, MF
Coetzee, GA
Citation: Jj. Park et al., Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor, CANCER RES, 60(21), 2000, pp. 5946-5949
Authors:
Wen, WH
Bernstein, L
Lescallett, J
Beazer-Barclay, Y
Sullivan-Halley, J
White, M
Press, MF
Citation: Wh. Wen et al., Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis, CANCER RES, 60(10), 2000, pp. 2716-2722
Authors:
Lukas, J
Niu, N
Press, MF
Citation: J. Lukas et al., p53 mutations and expression in breast carcinoma in situ, AM J PATH, 156(1), 2000, pp. 183-191
Authors:
Wilson, CA
Ramos, L
Villasenor, MR
Anders, KH
Press, MF
Clarke, K
Karlan, B
Chen, JJ
Scully, R
Livingston, D
Zuch, RH
Kanter, MH
Cohen, S
Calzone, FJ
Slamon, DJ
Citation: Ca. Wilson et al., Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas, NAT GENET, 21(2), 1999, pp. 236-240
Authors:
Wen, WH
Reles, A
Runnebaum, IB
Sullivan-Halley, J
Bernstein, L
Jones, LA
Felix, JC
Kreienberg, R
El-Naggar, A
Press, MF
Citation: Wh. Wen et al., p53 mutations and expression in ovarian cancers: Correlation with overall survival, INT J GYN P, 18(1), 1999, pp. 29-41
Authors:
Park, JHM
Yang, XW
Park, JJ
Press, OW
Press, MF
Citation: Jhm. Park et al., Assessment of novel anti-p185(HER-2) monoclonal antibodies for internalization-dependent therapies, HYBRIDOMA, 18(6), 1999, pp. 487-495
Authors:
Mitchell, MS
Press, MF
Citation: Ms. Mitchell et Mf. Press, The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 108-116
Authors:
Yang, XW
Uziely, B
Groshen, S
Lukas, J
Israel, V
Russell, C
Dunnington, G
Formenti, S
Muggia, F
Press, MF
Citation: Xw. Yang et al., MDR1 gene expression in primary and advanced breast cancer, LAB INV, 79(3), 1999, pp. 271-280
Authors:
Cozen, W
Bernstein, L
Wang, F
Press, MF
Mack, TM
Citation: W. Cozen et al., The risk of angiosarcoma following primary breast cancer, BR J CANC, 81(3), 1999, pp. 532-536
Risultati:
1-15
|